Scriptaid effects on breast cancer cell lines (Q39418737)

11 September 2017

Scriptaid effects on breast cancer cell lines (English)

1 reference

11 September 2017

E Rizzuto

4

0 references

author name string

L Giacinti

1

1 reference

11 September 2017

C Giacinti

2

1 reference

11 September 2017

C Gabellini

3

1 reference

11 September 2017

M Lopez

5

1 reference

11 September 2017

A Giordano

6

1 reference

11 September 2017

1 October 2012

1 reference

Journal of Cellular Physiology

11 September 2017

1 reference

11 September 2017

227

1 reference

11 September 2017

10

1 reference

11 September 2017

3426-3433

1 reference

CpG-rich islands and the function of DNA methylation

11 September 2017

1 reference

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

21 January 2018

1 reference

Novel Hydroxamate and Anilide Derivatives as Potent Histone Deacetylase Inhibitors: Synthesis and Antiproliferative Evaluation

21 January 2018

1 reference

Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors

21 January 2018

1 reference

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

21 January 2018

1 reference

Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression

21 January 2018

1 reference

The tumor suppressor role of CTCF.

21 January 2018

1 reference

Epigenetic information and estrogen receptor alpha expression in breast cancer

21 January 2018

1 reference

Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C.

21 January 2018

1 reference

Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer

21 January 2018

1 reference

Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding

21 January 2018

1 reference

Molecular action of the estrogen receptor and hormone dependency in breast cancer

21 January 2018

1 reference

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α

21 January 2018

1 reference

A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.

21 January 2018

1 reference

The loss of estrogen and progesterone receptor gene expression in human breast cancer

21 January 2018

1 reference

Connections and regulation of the human estrogen receptor

21 January 2018

1 reference

Proximal events in signaling by plasma membrane estrogen receptors

21 January 2018

1 reference

Steroid hormone receptor signaling in tumorigenesis

21 January 2018

1 reference

Histone deacetylase inhibitors in cancer treatment

21 January 2018

1 reference

Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.

21 January 2018

1 reference

Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.24043

1 reference

11 September 2017

1 reference